These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7105621)

  • 21. Furosemide kinetics and dynamics in patients with cirrhosis.
    Villeneuve JP; Verbeeck RK; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bumetanide and furosemide in heart failure.
    Brater DC; Day B; Burdette A; Anderson S
    Kidney Int; 1984 Aug; 26(2):183-9. PubMed ID: 6503136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of furosemide in advanced renal failure.
    Huang CM; Atkinson AJ; Levin M; Levin NW; Quintanilla A
    Clin Pharmacol Ther; 1974 Oct; 16(4):659-66. PubMed ID: 4422027
    [No Abstract]   [Full Text] [Related]  

  • 24. Furosemide kinetics and dynamics in aged patients.
    Kerremans AL; Tan Y; van Baars H; van Ginneken CA; Gribnau FW
    Clin Pharmacol Ther; 1983 Aug; 34(2):181-9. PubMed ID: 6872412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption and disposition of furosemide in congestive heart failure.
    Brater DC; Seiwell R; Anderson S; Burdette A; Dehmer GJ; Chennavasin P
    Kidney Int; 1982 Aug; 22(2):171-6. PubMed ID: 7132061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function.
    Traeger A; Stein G; Sperschneider H; Keil E
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):481-6. PubMed ID: 6500766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Furosemide kinetics in patients with hepatic cirrhosis with ascites.
    Fuller R; Hoppel C; Ingalls ST
    Clin Pharmacol Ther; 1981 Oct; 30(4):461-7. PubMed ID: 7285480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Furosemide disposition in cirrhotic patients.
    Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
    Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose furosemide in the treatment of refractory congestive heart failure.
    Gerlag PG; van Meijel JJ
    Arch Intern Med; 1988 Feb; 148(2):286-91. PubMed ID: 3341836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis.
    Riva E; Fossali E; Bettinelli A
    Eur J Clin Pharmacol; 1982; 21(4):303-6. PubMed ID: 7056274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
    Wehling M; Zimmermann J; Weil J; Gerzer R; Theisen K
    Z Kardiol; 1990 Feb; 79(2):120-5. PubMed ID: 2157313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
    Cleland JG; Gillen G; Dargie HJ
    Eur Heart J; 1988 Feb; 9(2):132-41. PubMed ID: 2832173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to furosemide in chronic renal insufficiency: rationale for limited doses.
    Brater DC; Anderson SA; Brown-Cartwright D
    Clin Pharmacol Ther; 1986 Aug; 40(2):134-9. PubMed ID: 3731676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic disposition and protein binding of furosemide in newborn infants.
    Aranda JV; Perez J; Sitar DS; Collinage J; Portuguez-Malavasi A; Duffy B; Dupont C
    J Pediatr; 1978 Sep; 93(3):507-11. PubMed ID: 690779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of furosemide in neonates.
    Vert P; Broquaire M; Legagneur M; Morselli PL
    Eur J Clin Pharmacol; 1982; 22(1):39-45. PubMed ID: 7094973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.
    Dormans TP; Gerlag PG
    Eur Heart J; 1996 Dec; 17(12):1867-74. PubMed ID: 8960430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sotalol kinetics in renal insufficiency.
    Blair AD; Burgess ED; Maxwell BM; Cutler RE
    Clin Pharmacol Ther; 1981 Apr; 29(4):457-63. PubMed ID: 7471612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics of frusemide are influenced by age.
    Andreasen F; Hansen U; Husted SE; Jansen JA
    Br J Clin Pharmacol; 1983 Oct; 16(4):391-7. PubMed ID: 6626433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of furosemide in geriatric patients.
    Mühlberg W; Platt D; Neubig E
    Arch Gerontol Geriatr; 1986 Oct; 5(3):249-63. PubMed ID: 3800492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.